Skip to main content
search

Assessing the Utility of a Remote Patient Monitoring Platform for Improving CPAP Adherence for Obstructive Sleep Apnea

Abstract

Obstructive sleep apnea (OSA) is highly prevalent and associated with adverse cardiovascular and metabolic outcomes. CPAP therapy is effective but long-term adherence is poor. While standard coaching improves outcomes, sustained adherence remains a challenge. Remote patient monitoring (RPM) platforms may provide an innovative method to improve adherence through continuous feedback, patient engagement, and structured escalation pathways. This randomized controlled trial will evaluate whether adding the MonitAir RPM platform to the standard-of-care program provided by BetterNight improves CPAP adherence and patient satisfaction over 90 days.

Aim

To evaluate whether adding the MonitAir remote patient monitoring (RPM) platform to BetterNight’s standard-of-care CPAP program improves adherence, patient satisfaction, and time to CMS-defined adherence in adults with obstructive sleep apnea.

Intended Impact of the Study

This study will provide some of the first randomized evidence evaluating a remote patient monitoring platform for CPAP adherence in real-world clinical practice. Findings will inform clinicians, digital health developers, and payers on how digital RPM can improve patient engagement, adherence, and outcomes in sleep medicine. The results may guide implementation strategies for RPM in other chronic disease areas.

Project Lead

Ricardo De Armas, MD, MBA

Project Collaborators

Dominic Munafo
Bretton Lane
William Hevener
Simba Nyanhongo
Edward Mezerhane
Aron Bobrowski

Contact Project Author

Keywords

CPAP adherence; Remote patient monitoring; obstructive sleep apnea; patient engagement; randomized trial; sleep medicine; telehealth

Research Area(s)

Data visualization; Design and conduct of studies; Digital tools; Recruitment and retention; Reporting standards

Other Areas: Remote patient monitoring, CPAP adherence, digital health interventions, telehealth, sleep medicine, patient engagement, implementation science.

Study Design(s)

Parallel-group study (2 arms, 1:1 allocation); Randomised controlled trial

Other Designs: Randomized, controlled, parallel-group trial (2 arms, 1:1 allocation, 200 participants total, 90-day follow-up).

Data Collection Method(s)

Qualitative, Quantitative

Participant(s)

Patients

Other Participants: Adults (≥18 years) with obstructive sleep apnea (AHI ≥5), initiating CPAP/APAP therapy, owning a smartphone, and able to engage in telemonitoring. Excluded: DOT drivers, central apnea predominance, use of BiPAP/ASV, or unwillingness to participate.

Status

Complete

Stage

Data analysis; Publication (writing, submitting, in review, published); Study is complete and only conducting dissemination activities (e.g., stakeholder engagement, presentations, conferences and seminars, social media campaigns)

Study Funding/Support

Industry-sponsored collaboration between MonitAir LLC and BetterNight, not supported by an external research grant.; Other

Other(s): Industry-sponsored collaboration between MonitAir LLC and BetterNight, without external grant funding.

Dissemination Activity/Activities

Publications (all types)

Other(s): Preparation of peer-reviewed manuscript; abstract submission to national sleep and cardiology conferences; dissemination through partner clinics and digital health networks.